GENERATION BIO CO's ticker is GBIO and the CUSIP is 37148K100. A total of 98 filers reported holding GENERATION BIO CO in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $251,550 | -31.1% | 66,372 | 0.0% | 0.00% | 0.0% |
Q2 2023 | $365,046 | +32.3% | 66,372 | +3.4% | 0.00% | 0.0% |
Q1 2023 | $275,940 | +7.5% | 64,172 | -1.8% | 0.00% | 0.0% |
Q4 2022 | $256,755 | -26.0% | 65,332 | 0.0% | 0.00% | -50.0% |
Q3 2022 | $347,000 | -19.1% | 65,332 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $429,000 | -14.5% | 65,332 | -4.5% | 0.00% | 0.0% |
Q1 2022 | $502,000 | +232.5% | 68,392 | +221.6% | 0.00% | +100.0% |
Q4 2021 | $151,000 | -71.7% | 21,269 | -0.2% | 0.00% | -50.0% |
Q3 2021 | $534,000 | -38.8% | 21,312 | -34.3% | 0.00% | -50.0% |
Q2 2021 | $873,000 | -6.4% | 32,442 | -1.1% | 0.00% | 0.0% |
Q1 2021 | $933,000 | – | 32,792 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Atlas Venture Life Science Advisors, LLC | 8,278,876 | $43,961,000 | 4.85% |
GREAT POINT PARTNERS LLC | 825,077 | $4,381,000 | 1.06% |
HighVista Strategies LLC | 248,994 | $1,322,000 | 0.76% |
Artal Group S.A. | 2,814,191 | $14,943,000 | 0.64% |
PFM Health Sciences, LP | 3,013,712 | $16,003,000 | 0.58% |
HARVARD MANAGEMENT CO INC | 510,354 | $2,710,000 | 0.34% |
Yiheng Capital Management, L.P. | 997,857 | $5,299,000 | 0.33% |
Bellevue Group AG | 3,627,280 | $19,261,000 | 0.28% |
BVF INC/IL | 361,824 | $1,921,000 | 0.08% |
FARALLON CAPITAL MANAGEMENT LLC | 2,500,000 | $13,275,000 | 0.07% |